FDA approves Regeneron's Pasatru for rare bone disorder FOP
Go back to FDA approves Regeneron's Pasatru for rare bone disorder FOP| Regeneron (NASDAQ: REGN) | Delayed: 806.17 -4.14 (0.51%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $810.31 | 52 Week High | $592.36 | |||
| Open | $803.83 | 52 Week Low | $325.35 | |||
| Day High | $808.63 | P/E | 211.59 | |||
| Day Low | $796.73 | EPS | $3.81 | |||
| Volume | 227,699 | |||||
